Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359930 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01359930 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 16 participants.
The verdict
NCT01359930, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.
Interventions
- OTHER placebo
- DRUG Naltrexone and Bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01359930
The ClinicalTrials.gov registry entry for NCT01359930 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01359930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01359930 about?
NCT01359930 is a clinical study titled "Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study". The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.
What is the current status of trial NCT01359930?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2011-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01359930?
The interventions under investigation include: placebo (OTHER), Naltrexone and Bupropion SR (DRUG).
Who is sponsoring clinical trial NCT01359930?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.